Is CHEK2 a moderate-risk breast cancer gene or the younger sister of Li-Fraumeni?

Abstract excerpt

The CHEK2 gene is mostly considered as a moderate breast cancer gene with the result that many clinicians have a narrow focus. We present the 10-year journey of a man who had five different cancers and had iterative genetic testing including for Li-Fraumeni syndrome, eventually to discover a pathogenic variant in the CHEK2 gene, possibly explaining his numerous cancers. This diagnosis offered him closure which he...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Breast Neoplasms, Male
• Share to Checkpoint Kinase 2
• Share to Li-Fraumeni Syndrome